Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Total 13F shares
-
15,384,544
-
Share change
-
+1,091,447
-
Total reported value
-
$664,817,567
-
Price per share
-
$43.38
-
Number of holders
-
64
-
Value change
-
+$47,822,437
-
Number of buys
-
40
-
Number of sells
-
28
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q1 2021
As of 31 Mar 2021,
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,384,544 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, FMR LLC, JANUS HENDERSON GROUP PLC, ArrowMark Colorado Holdings LLC, BVF INC/IL, Casdin Capital, LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.